Synucleinopathies Take Their Toll: Are TLRs a Way to Go?

Autor: Mazzotta GM; Department of Biology, University of Padova, 35131 Padova, Italy., Ceccato N; Department of Biology, University of Padova, 35131 Padova, Italy., Conte C; Department of Pharmaceutical Sciences, University of Perugia, 06100 Perugia, Italy.
Jazyk: angličtina
Zdroj: Cells [Cells] 2023 Apr 24; Vol. 12 (9). Date of Electronic Publication: 2023 Apr 24.
DOI: 10.3390/cells12091231
Abstrakt: The misfolding and subsequent abnormal accumulation and aggregation of α-Synuclein (αSyn) as insoluble fibrils in Lewy bodies and Lewy neurites is the pathological hallmark of Parkinson's disease (PD) and several neurodegenerative disorders. A combination of environmental and genetic factors is linked to αSyn misfolding, among which neuroinflammation is recognized to play an important role. Indeed, a number of studies indicate that a Toll-like receptor (TLR)-mediated neuroinflammation might lead to a dopaminergic neural loss, suggesting that TLRs could participate in the pathogenesis of PD as promoters of immune/neuroinflammatory responses. Here we will summarize our current understanding on the mechanisms of αSyn aggregation and misfolding, focusing on the contribution of TLRs to the progression of α-synucleinopathies and speculating on their link with the non-motor disturbances associated with aging and neurodegenerative disorders.
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje